-
Something wrong with this record ?
Metabolic and cardiovascular adaptations to an 8-wk lifestyle weight loss intervention in younger and older obese men
J. Vion, V. Sramkova, E. Montastier, MA. Marquès, S. Caspar-Bauguil, T. Duparc, LO. Martinez, V. Bourlier, I. Harant, D. Larrouy, N. Moussaoui, S. Bonnel, C. Vindis, C. Dray, P. Valet, JS. Saulnier-Blache, JP. Schanstra, C. Thalamas, N. Viguerie,...
Language English Country United States
Document type Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- Adult MeSH
- Adaptation, Physiological * MeSH
- Cardiovascular System metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Obesity metabolism MeSH
- Weight Reduction Programs * MeSH
- Aged MeSH
- Body Composition MeSH
- Age Factors MeSH
- Life Style * MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Publication type
- Journal Article MeSH
- Clinical Trial MeSH
- Research Support, Non-U.S. Gov't MeSH
The number of older obese adults is increasing worldwide. Whether obese adults show similar health benefits in response to lifestyle interventions at different ages is unknown. The study enrolled 25 obese men (body mass index: 31-39 kg/m2) in two arms according to age (30-40 and 60-70 yr old). Participants underwent an 8-wk intervention with moderate calorie restriction (∼20% below individual energy requirements) and supervised endurance training resulting in ∼5% weight loss. Body composition was measured using dual energy X-ray absorptiometry. Insulin sensitivity was assessed during a hypersinsulinemic-euglycemic clamp. Cardiometabolic profile was derived from blood parameters. Subcutaneous fat and vastus lateralis muscle biopsies were used for ex vivo analyses. Two-way repeated-measure ANOVA and linear mixed models were used to evaluate the response to lifestyle intervention and comparison between the two groups. Fat mass was decreased and bone mass was preserved in the two groups after intervention. Muscle mass decreased significantly in older obese men. Cardiovascular risk (Framingham risk score, plasma triglyceride, and cholesterol) and insulin sensitivity were greatly improved to a similar extent in the two age groups after intervention. Changes in adipose tissue and skeletal muscle transcriptomes were marginal. Analysis of the differential response to the lifestyle intervention showed tenuous differences between age groups. These data suggest that lifestyle intervention combining calorie restriction and exercise shows similar beneficial effects on cardiometabolic risk and insulin sensitivity in younger and older obese men. However, attention must be paid to potential loss of muscle mass in response to weight loss in older obese men.NEW & NOTEWORTHY Rise in obesity and aging worldwide are major trends of critical importance in public health. This study addresses a current challenge in obesity management. Do older obese adults respond differently to a lifestyle intervention composed of moderate calorie restriction and supervised physical activity than younger ones? The main conclusion of the study is that older and younger obese men similarly benefit from the intervention in terms of cardiometabolic risk.
Department of Pathophysiology 3rd Faculty of Medicine Charles University Prague Czech Republic
Departments of Nutrition and Clinical Biochemistry Toulouse University Hospitals Toulouse France
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024980
- 003
- CZ-PrNML
- 005
- 20211026134232.0
- 007
- ta
- 008
- 211013s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1152/ajpendo.00109.2021 $2 doi
- 035 __
- $a (PubMed)34250814
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Vion, Julie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 245 10
- $a Metabolic and cardiovascular adaptations to an 8-wk lifestyle weight loss intervention in younger and older obese men / $c J. Vion, V. Sramkova, E. Montastier, MA. Marquès, S. Caspar-Bauguil, T. Duparc, LO. Martinez, V. Bourlier, I. Harant, D. Larrouy, N. Moussaoui, S. Bonnel, C. Vindis, C. Dray, P. Valet, JS. Saulnier-Blache, JP. Schanstra, C. Thalamas, N. Viguerie, C. Moro, D. Langin
- 520 9_
- $a The number of older obese adults is increasing worldwide. Whether obese adults show similar health benefits in response to lifestyle interventions at different ages is unknown. The study enrolled 25 obese men (body mass index: 31-39 kg/m2) in two arms according to age (30-40 and 60-70 yr old). Participants underwent an 8-wk intervention with moderate calorie restriction (∼20% below individual energy requirements) and supervised endurance training resulting in ∼5% weight loss. Body composition was measured using dual energy X-ray absorptiometry. Insulin sensitivity was assessed during a hypersinsulinemic-euglycemic clamp. Cardiometabolic profile was derived from blood parameters. Subcutaneous fat and vastus lateralis muscle biopsies were used for ex vivo analyses. Two-way repeated-measure ANOVA and linear mixed models were used to evaluate the response to lifestyle intervention and comparison between the two groups. Fat mass was decreased and bone mass was preserved in the two groups after intervention. Muscle mass decreased significantly in older obese men. Cardiovascular risk (Framingham risk score, plasma triglyceride, and cholesterol) and insulin sensitivity were greatly improved to a similar extent in the two age groups after intervention. Changes in adipose tissue and skeletal muscle transcriptomes were marginal. Analysis of the differential response to the lifestyle intervention showed tenuous differences between age groups. These data suggest that lifestyle intervention combining calorie restriction and exercise shows similar beneficial effects on cardiometabolic risk and insulin sensitivity in younger and older obese men. However, attention must be paid to potential loss of muscle mass in response to weight loss in older obese men.NEW & NOTEWORTHY Rise in obesity and aging worldwide are major trends of critical importance in public health. This study addresses a current challenge in obesity management. Do older obese adults respond differently to a lifestyle intervention composed of moderate calorie restriction and supervised physical activity than younger ones? The main conclusion of the study is that older and younger obese men similarly benefit from the intervention in terms of cardiometabolic risk.
- 650 12
- $a fyziologická adaptace $7 D000222
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a složení těla $7 D001823
- 650 _2
- $a kardiovaskulární systém $x metabolismus $7 D002319
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a životní styl $7 D008019
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a obezita $x metabolismus $7 D009765
- 650 12
- $a programy na snížení hmotnosti $7 D061217
- 655 _2
- $a klinické zkoušky $7 D016430
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Sramkova, Veronika $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Department of Pathophysiology, Third Faculty of Medicine, Charles University, Prague, Czech Republic $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France
- 700 1_
- $a Montastier, Emilie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France $u Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France
- 700 1_
- $a Marquès, Marie-Adeline $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France
- 700 1_
- $a Caspar-Bauguil, Sylvie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France $u Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France
- 700 1_
- $a Duparc, Thibaut $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Martinez, Laurent O $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Bourlier, Virginie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Harant, Isabelle $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Larrouy, Dominique $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Moussaoui, Nabila $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Bonnel, Sophie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Vindis, Cécile $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Clinical Investigation Center, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Toulouse University Hospitals, CIC1436, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Dray, Cédric $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Valet, Philippe $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Saulnier-Blache, Jean-Sébastien $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Schanstra, Joost P $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Thalamas, Claire $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Clinical Investigation Center, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, Toulouse University Hospitals, CIC1436, F-CRIN/FORCE Network, Toulouse, France
- 700 1_
- $a Viguerie, Nathalie $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France
- 700 1_
- $a Moro, Cedric $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France
- 700 1_
- $a Langin, Dominique $u Institute of Metabolic and Cardiovascular Diseases, I2MC Team MetaDiab, Université de Toulouse, INSERM, Université Toulouse III-Paul Sabatier, UMR 1297, F-CRIN/FORCE Network, Toulouse, France $u Franco-Czech Laboratory for Clinical Research on Obesity, Third Faculty of Medicine, Prague, Czech Republic, Paul Sabatier University, Toulouse, France $u Departments of Nutrition and Clinical Biochemistry, Toulouse University Hospitals, Toulouse, France $u Institut Universitaire de France, IUF, Paris, France
- 773 0_
- $w MED00000286 $t American journal of physiology. Endocrinology and metabolism $x 1522-1555 $g Roč. 321, č. 3 (2021), s. E325-E337
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34250814 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20211013 $b ABA008
- 991 __
- $a 20211026134238 $b ABA008
- 999 __
- $a ok $b bmc $g 1714151 $s 1145487
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 321 $c 3 $d E325-E337 $e 20210712 $i 1522-1555 $m American journal of physiology: endocrinology and metabolism $n Am J Physiol Endocrinol Metab $x MED00000286
- LZP __
- $a Pubmed-20211013